Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy BRITISH JOURNAL OF HAEMATOLOGY Coutre, S. E., Othus, M., Powell, B., Willman, C. L., Stock, W., Paietta, E., Levitan, D., Wetzler, M., Attar, E. C., Altman, J. K., Gore, S. D., Maher, T., Kopecky, K. J., Tallman, M. S., Larson, R. A., Appelbaum, F. R. 2014; 165 (4): 497-503

View details for DOI 10.1111/bjh.12775

View details for Web of Science ID 000334686500007